New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology

Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · see citing works

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · see citing works

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110 · see citing works

The acute phase response

Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907 · see citing works

Liver Regeneration

Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828 · see citing works

IL-6 as a keystone cytokine in health and disease

Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511 · see citing works

Primary liver cancer: Worldwide incidence and trends

Bosch, F. X., Ribes, J., Díaz, M., & Clèries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,473 · see citing works

Genomic atlas of the human plasma proteome

Sun, B. B., Maranville, J. C., Peters, J. E., Stacey, D., Staley, J. R., Blackshaw, J., Burgess, S., Jiang, T., Paige, E., Surendran, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0175-2 · Cited by 2,268 · see citing works

Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB

Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · see citing works

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · see citing works

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

Habeeb, A. F. S. A. (1966) · Analytical Biochemistry · doi:10.1016/0003-2697(66)90275-2 · Cited by 2,040 · see citing works

Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production

Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955 · see citing works

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

Sandborn, W. J., Su, C. G., Sands, B. E., D’Haens, G., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,783 · see citing works

Impaired immune and acute-phase responses in interleukin-6-deficient mice

Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · see citing works

Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps

Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744 · see citing works

Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice

Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,536 · see citing works

Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis

Smillie, C. S., Biton, M., Ordovás-Montañés, J., Sullivan, K. M., Burgin, G., Graham, D. B., Herbst, R. H., Rogel, N., Slyper, M., Waldman, J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.029 · Cited by 1,386 · see citing works

Liver regeneration

Michalopoulos, G. K. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21172 · Cited by 1,384 · see citing works

Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo

Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293 · see citing works

Interleukin-6-deficient mice develop mature-onset obesity

Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · see citing works

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

Bastard, J., Jardel, C., Bruckert, É., Blondy, P., Capeau, J., Laville, M., Vidal, H., & Hainque, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6839 · Cited by 1,102 · see citing works

Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer

Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102 · see citing works

Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6

Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Pedersen, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00237.x · Cited by 1,095 · see citing works

Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojković, O., et al. (2007) · Nature · doi:10.1038/nature06096 · Cited by 987 · see citing works

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922 · see citing works

Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer

Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862 · see citing works

Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease

REINECKER, H.-C., STEFFEN, M., Witthoeft, T., Pflüger, I., Schreiber, S., MacDermott, R. P., & Raedler, A. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 855 · see citing works

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

Oxford IBD Cohort Investigators, West, N. R., Hegazy, A. N., Owens, B. M. J., Bullers, S. J., Linggi, B. E., Buonocore, S. M., Coccia, M., Görtz, D., This, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4307 · Cited by 814 · see citing works

Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

Sandborn, W. J., Ghosh, S. K., Panés, J., Vranic, I. I., Su, C. G., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800 · see citing works

Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin

Mauer, J., Chaurasia, B., Goldau, J., Vogt, M. C., Ruud, J., Nguyen, K. D., Theurich, S., Hausen, A. C., Schmitz, J., Brönneke, H. S., et al. (2014) · Nature Immunology · doi:10.1038/ni.2865 · Cited by 727 · see citing works

Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes

Perry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719 · see citing works

Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity

Minegishi, Y., Saitō, M., Morio, T., Watanabe, K., Agematsu, K., Tsuchiya, S., Takada, H., Hara, T., Kawamura, N., Ariga, T., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.009 · Cited by 701 · see citing works

Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.

Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M., & Rose-John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 665 · see citing works

The role of hepatocytes and oval cells in liver regeneration and repopulation

Fausto, N., & Campbell, J. S. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00338-6 · Cited by 646 · see citing works

Interleukin-6: designing specific therapeutics for a complex cytokine

Garbers, C., Heink, S., Korn, T., & Rose-John, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.45 · Cited by 643 · see citing works

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease☆

Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636 · see citing works

A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance

Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604 · see citing works

Disruption of the CNTF gene results in motor neuron degeneration

Masu, Y., Wolf, E., Holtmann, B., Sendtner, M., Brem, G., & Thoenen, H. (1993) · Nature · doi:10.1038/365027a0 · Cited by 558 · see citing works

Interleukin-6: Biology, signaling and strategies of blockade

Schaper, F., & Rose‐John, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.004 · Cited by 511 · see citing works

The soluble interleukin‐6 receptor is generated by shedding

Müllberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A. A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 507 · see citing works

Common variants at five new loci associated with early-onset inflammatory bowel disease

Imielinski, M. B., Baldassano, R. N., Griffiths, A. M., Russell, R. K., Annese, V., Dubinsky, M. C., Kugathasan, S., Bradfield, J. P., Walters, T. D., Abou‐Sleiman, P. M., et al. (2009) · Nature Genetics · doi:10.1038/ng.489 · Cited by 482 · see citing works

Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477 · see citing works

Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice

Tebbutt, N. C., Giraud, A. S., Inglese, M., Jenkins, B., Waring, P., Clay, F. J., Malki, S., Alderman, B. M., Grail, D., Hollande, F., et al. (2002) · Nature Medicine · doi:10.1038/nm763 · Cited by 474 · see citing works

Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease

Lee, J., Hall, J. A., Kroehling, L., Wu, L., Najar, T. A., Nguyen, H. H., Lin, W.-Y., Yeung, S. T., Silva, H. M., Li, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.11.026 · Cited by 472 · see citing works

The IBD interactome: an integrated view of aetiology, pathogenesis and therapy

de Souza, H. S. P., Fiocchi, C., & Iliopoulos, D. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.110 · Cited by 447 · see citing works

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

Vermeire, S., Schreiber, S., Petryka, R., Kuehbacher, T., Hebuterne, X., Roblin, X., Klopocka, M., Goldis, A., Wisniewska-Jarosinska, M., Baranovsky, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32537-5 · Cited by 439 · see citing works

Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

Shi, Y., Gao, W., Lytle, N. K., Huang, P., Yuan, X., Dann, A. M., Ridinger-Saison, M., DelGiorno, K. E., Antal, C. E., Liang, G., et al. (2019) · Nature · doi:10.1038/s41586-019-1130-6 · Cited by 431 · see citing works

Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically

Putoczki, T. L., Thiem, S., Loving, A., Busuttil, R. A., Wilson, N. J., Ziegler, P. K., Nguyen, P. M., Preaudet, A., Farid, R., Edwards, K. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.017 · Cited by 423 · see citing works

Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent

Camargo, C. A., Madden, J. F., Gao, W., Selvan, R. S., & Clavien, P. (1997) · Hepatology · doi:10.1002/hep.510260619 · Cited by 420 · see citing works

<i>STAT3</i> Plays a Critical Role in <i>KRAS</i> -Induced Pancreatic Tumorigenesis

Corcoran, R. B., Contino, G., Deshpande, V., Tzatsos, A., Conrad, C., Benes, C. H., Levy, D. E., Settleman, J., Engelman, J. A., & Bardeesy, N. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0908 · Cited by 413 · see citing works

IL-6 is required for the development of Th1 cell-mediated murine colitis

Yamamoto, M., Yoshizaki, K., Kishimoto, T., & Ito, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4878 · Cited by 411 · see citing works

Structural Biology of Shared Cytokine Receptors

Wang, X., Lupardus, P. J., LaPorte, S. L., & García, K. C. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090616 · Cited by 407 · see citing works

A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis

ALS CNTF Treatment Study Group (1996) · Neurology · doi:10.1212/wnl.46.5.1244 · Cited by 405 · see citing works

Exercise-Induced Changes in Visceral Adipose Tissue Mass Are Regulated by IL-6 Signaling: A Randomized Controlled Trial

Wedell-Neergaard, A.-S., Lang Lehrskov, L., Christensen, R. H., Legaard, G. E., Dorph, E., Larsen, M. K., Launbo, N., Fagerlind, S. R., Seide, S. K., Nymand, S., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.007 · Cited by 403 · see citing works

Impaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice

Gallucci, R. M., Simeonova, P. P., Matheson, J. M., Kommineni, C., Guriel, J. L., Sugawara, T., & Luster, M. I. (2000) · The FASEB Journal · doi:10.1096/fj.00-0073com · Cited by 402 · see citing works

Induction of rat acute‐phase proteins by interleukin 6 in vivo

Geiger, T. M., Andus, T., Klapproth, J., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180510 · Cited by 401 · see citing works

Plasticity and cross-talk of Interleukin 6-type cytokines

Garbers, C., Hermanns, H. M., Schaper, F., Müller‐Newen, G., Grötzinger, J., Rose‐John, S., & Scheller, J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.001 · Cited by 401 · see citing works

Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells

Heink, S., Yogev, N., Garbers, C., Herwerth, M., Aly, L., Gasperi, C., Husterer, V., Croxford, A. L., Möller‐Hackbarth, K., Bartsch, H. S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3632 · Cited by 401 · see citing works

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

Panés, J., Sandborn, W. J., Schreiber, S., Sands, B. E., Vermeire, S., D’Haens, G., Panaccione, R., Higgins, P., Colombel, J., Feagan, B. G., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312735 · Cited by 374 · see citing works

Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations.

Sobala, G. M., Crabtree, J. E., Dixon, M. F., et al. (1991) · Gut · doi:10.1136/gut.32.11.1415 · Cited by 352 · see citing works

STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice

Ernst, M., Najdovska, M., Grail, D., Lundgren–May, T., Büchert, M., Tye, H., Matthews, V. B., Armes, J. E., Bhathal, P. S., Hughes, N. R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34944 · Cited by 346 · see citing works

Regulation of Adipose Tissue Inflammation by Interleukin 6

Han, M. S., White, A., Perry, R. J., Camporez, J.-P., Hidalgo, J., Shulman, G. I., & Davis, R. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920004117 · Cited by 344 · see citing works

Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis

Li, Y., de Haar, C., Chen, M., Deuring, J., Gerrits, M. M., Smits, R., Xia, B., Kuipers, E. J., & van der Woude, C. J. (2010) · Gut · doi:10.1136/gut.2009.184176 · Cited by 339 · see citing works

Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance

Matthews, V. B., Allen, T. L., Risis, S., Chan, M. H. S., Henstridge, D. C., Watson, N., Zaffino, L. A., Babb, J. R., Boon, J., Meikle, P. J., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1865-y · Cited by 334 · see citing works

Essential Role of STAT3 in the Control of the Acute-Phase Response as Revealed by Inducible Gene Activation in the Liver

Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., & Poli, V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1621-1632.2001 · Cited by 329 · see citing works

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

Sandborn, W. J., Feagan, B. G., Loftus, E. V., Peyrin-Biroulet, L., Van Assche, G., D’Haens, G., Schreiber, S., Colombel, J.-F., Lewis, J. D., Ghosh, S., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.047 · Cited by 322 · see citing works

Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling

Jenkins, B. J., Grail, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R. M., Jones, S. A., Topley, N., et al. (2005) · Nature Medicine · doi:10.1038/nm1282 · Cited by 308 · see citing works

Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.

Limpens, J., de Jong, D., van Krieken, J. H., et al. (1991) · PubMed · Cited by 299 · see citing works

The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling

Ungureanu, D., Wu, J., Pekkala, T., Niranjan, Y., Young, C., Jensen, O. N., Xu, C., Neubert, T. A., Skoda, R. C., Hubbard, S. R., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2099 · Cited by 277 · see citing works

Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

Widjaja, A. A., Singh, B. K., Adami, E., Viswanathan, S., Dong, J., D’Agostino, G. A., Ng, B., Lim, W., Tan, J., Paleja, B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.002 · Cited by 276 · see citing works

CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK

Watt, M. J., Dzamko, N. L., Thomas, W. G., Rose‐John, S., Ernst, M., Carling, D., Kemp, B. E., Febbraio, M. A., & Steinberg, G. R. (2006) · Nature Medicine · doi:10.1038/nm1383 · Cited by 275 · see citing works

Dual control of C‐reactive protein gene expression by interleukin‐1 and interleukin‐6.

Ganter, U., Arcone, R., Toniatti, C., Morrone, G., & Ciliberto, G. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08554.x · Cited by 265 · see citing works

Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family.

Senaldi, G., Varnum, B., Sarmiento, U., Starnes, C., Lile, J., Scully, S., Guo, J., Elliott, G., McNinch, J., Shaklee, C. L., et al. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.20.11458 · Cited by 265 · see citing works

Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance

Zhang, Y., Yan, W., Collins, M. A., Bednar, F., Rakshit, S., Zetter, B. R., Stanger, B. Z., Chung, I., Rhim, A. D., & di Magliano, M. P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1558-t · Cited by 261 · see citing works

Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

Schreiber, S., Aden, K., Bernardes, J. P., Conrad, C., Tran, F., Höper, H., Volk, V., Mishra, N., Blase, J. I., Nikolaus, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.062 · Cited by 259 · see citing works

Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor

McFarland-Mancini, M. M., Funk, H. M., Paluch, A. M., Zhou, M., Giridhar, P. V., Mercer, C. A., Kozma, S. C., & Drew, A. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901929 · Cited by 249 · see citing works

Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas

Pilati, C., Amessou, M., Bihl, M., Balabaud, C. P., Nhieu, J. T. V., Paradis, V., Nault, J., Izard, T., Bioulac‐Sage, P., Couchy, G., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110283 · Cited by 242 · see citing works

IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling

Timper, K., Denson, J. L., Steculorum, S. M., Heilinger, C., Engström, L., Wunderlich, C. M., Rose‐John, S., Wunderlich, F. T., & Brüning, J. C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.043 · Cited by 233 · see citing works

Systematic review of the association between circulating interleukin-6 (IL-6) and cancer

Heikkilä, K., Ebrahim, S., & Lawlor, D. A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.047 · Cited by 232 · see citing works

Activation Pattern of Signal Transducers and Activators of Transcription (STAT) Factors in Inflammatory Bowel Diseases

Mudter, J., Weigmann, B., Bartsch, B., Kießlich, R., Strand, D. J., Galle, P. R., Lehr, H. A., Schmidt, J., & Neurath, M. F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40615.x · Cited by 231 · see citing works

Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice

Metcalf, D., Nicola, N. A., & Gearing, D. (1990) · Blood · doi:10.1182/blood.v76.1.50.50 · Cited by 229 · see citing works

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action

Wunderlich, F. T., Ströhle, P., Könner, A. C., Gruber, S., Tovar, S., Brönneke, H. S., Juntti-Berggren, L., Li, L.-S., van Rooijen, N., Libert, C., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.011 · Cited by 229 · see citing works

Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation

Ernst, M., Inglese, M., Waring, P., Campbell, I. K., Bao, S., Clay, F. J., Alexander, W. S., Wicks, I. P., Tarlinton, D. M., Novak, U., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.2.189 · Cited by 227 · see citing works

Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant

Boisson‐Dupuis, S., Ramirez‐Alejo, N., Li, Z., Patin, É., Rao, G., Kerner, G., Lim, C. K., Krementsov, D. N., Hernandez, N., Ma, C. S., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aau8714 · Cited by 208 · see citing works

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.

Ettinger, M. P., Littlejohn, T. W., Schwartz, S. L., Weiss, S. R., McIlwain, H. H., Heymsfield, S. B., Bray, G. A., Roberts, W. G., Heyman, E. R., Stambler, N., et al. (2003) · PubMed · doi:10.1001/jama.289.14.1826 · Cited by 206 · see citing works

Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses

Spencer, S., Bal, S. K., Egner, W., Allen, H. L., Raza, S. I., Ma, C. A., Gürel, M., Zhang, Y., Sun, G., Sabroe, R. A., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190344 · Cited by 206 · see citing works

Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6.

Baumann, H., & Schendel, P. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54940-1 · Cited by 204 · see citing works

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease

Sands, B. E., Bank, S., Sninsky, C. A., Robinson, M., Katz, S., Singleton, J. W., Miner, P. B., Safdi, M. A., Galandiuk, S., Hanauer, S. B., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70550-0 · Cited by 204 · see citing works

The Enigmatic Cytokine Oncostatin M and Roles in Disease

Richards, C. D. (2013) · ISRN Inflammation · doi:10.1155/2013/512103 · Cited by 204 · see citing works

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis

Schwerd, T., Twigg, S. R. F., Aschenbrenner, D., Manrique, S., Miller, K. A., Taylor, I. B., Capitani, M., McGowan, S. J., Sweeney, E. A., Weber, A. P., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161810 · Cited by 204 · see citing works

Interleukin 6 Is Important for Survival After Partial Hepatectomy in Mice

Blindenbacher, A., Wang, X., Langer, I., Savino, R., Terracciano, L., & Heim, M. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50378 · Cited by 202 · see citing works

Fimbrin is a cytoskeletal protein that crosslinks F-actin in vitro.

Bretscher, A. P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6849 · Cited by 201 · see citing works

The IL-6–gp130–STAT3 pathway in hepatocytes triggers liver protection in T cell–mediated liver injury

Klein, C., Wüstefeld, T., Assmus, U., Roskams, T., Rose-John, S., Müller, M., Manns, M. P., Ernst, M., & Trautwein, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523640 · Cited by 200 · see citing works

Constitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease

Lovato, P., Brender, C., Agnholt, J. S., Kelsen, J., Kaltoft, K., Svejgaard, A., Eriksen, K. W., Woetmann, A., & Ødum, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207999200 · Cited by 199 · see citing works

Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review

Fabre, A., Marchal, S., Barlogis, V., Mari, B. P., Barbry, P., Rohrlich, P., Forbes, L. R., Vogel, T. P., & Giovannini‐Chami, L. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.02.018 · Cited by 194 · see citing works

Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice

Hanson, M. L., Hixon, J. A., Li, W., Felber, B. K., Anver, M. R., Stewart, C. A., Janelsins, B., Datta, S. K., Shen, W., McLean, M. H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.060 · Cited by 193 · see citing works

STAT3, a key regulator in liver fibrosis.

Zhao, J., Qi, Y.-F., & Yu, Y.-R. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.06.010 · Cited by 190 · see citing works

Null Leukemia Inhibitory Factor Receptor (LIFR) Mutations in Stüve-Wiedemann/Schwartz-Jampel Type 2 Syndrome

Dagoneau, N., Scheffer, D. I., Huber, C., Al-Gazali, L. I., Rocco, M. D., Godard, A., Martinovic, J., Raas‐Rothschild, A., Sigaudy, S., Unger, S., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381715 · Cited by 189 · see citing works

Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.

Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 185 · see citing works

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Danese, S., Vermeire, S., Hellstern, P., Panaccione, R., Rogler, G., Fraser, G., Kohn, A., Desreumaux, P., Leong, R. W., Comer, G. M., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314562 · Cited by 181 · see citing works

Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130

Judd, L. M., Alderman, B. M., Howlett, M., Shulkes, A., Dow, C., Moverley, J., Grail, D., Jenkins, B. J., Ernst, M., & Giraud, A. S. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.10.066 · Cited by 180 · see citing works

Recurrent Staphylococcal Cellulitis and Subcutaneous Abscesses in a Child with Autoantibodies against IL-61

Puel, A., Picard, C., Lorrot, M., Pons, C., Chrabieh, M., Lorenzo, L., Mamani-Matsuda, M., Jouanguy, E., Gendrel, D., & Casanova, J. (2008) · Journal of Immunology · doi:10.4049/jimmunol.180.1.647 · Cited by 176 · see citing works

Extramedullary Expansion of Hematopoietic Progenitor Cells in Interleukin (IL)-6–sIL-6R Double Transgenic Mice

Peters, M., Schirmacher, P., Goldschmitt, J., Odenthal, M., Peschel, C., Fattori, E., Ciliberto, G., Dienes, H., Buschenfelde, K. Z. Z., & Rose-John, S. (1997) · Journal of Experimental Medicine · doi:10.1084/jem.185.4.755 · Cited by 176 · see citing works

Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations

Wilmes, S., Hafer, M., Vuorio, J., Tucker, J. A., Winkelmann, H., Löchte, S., Stanly, T. A., Prieto, K. D. P., Poojari, C., Sharma, V., et al. (2020) · Science · doi:10.1126/science.aaw3242 · Cited by 175 · see citing works

Ciliary neurotrophic factor: Pharmacokinetics and acute‐phase response in rat

Dittrich, F., Theonen, H., & Sendtner, M. (1994) · Annals of Neurology · doi:10.1002/ana.410350206 · Cited by 171 · see citing works

Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model

Barkhausen, T., Tschernig, T., Rosenstiel, P., van Griensven, M., Vonberg, R.-P., Dorsch, M., Mueller-Heine, A., Chalaris, A., Scheller, J., Rose-John, S., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318211ff56 · Cited by 169 · see citing works

The soluble interleukin 6 receptor: advanced therapeutic options in inflammation

Rose‐John, S. (2017) · Clinical Pharmacology &amp; Therapeutics · doi:10.1002/cpt.782 · Cited by 169 · see citing works

Immune and Inflammatory Responses toHelicobacter pyloriInfection

Crabtree, J. E. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609094526 · Cited by 163 · see citing works

Human IL6 enhances leptin action in mice

Sadagurski, M., Norquay, L., Farhang, J., D’Aquino, K. E., Copps, K. D., & White, M. F. (2009) · Diabetologia · doi:10.1007/s00125-009-1580-8 · Cited by 161 · see citing works

Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3

Riehle, K. J., Campbell, J. S., McMahan, R. S., Johnson, M. M., Beyer, R. P., Bammler, T. K., & Fausto, N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070820 · Cited by 161 · see citing works

Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice

Nakamura, K., Nonaka, H., Saito, H., Tanaka, M., & Miyajima, A. (2004) · Hepatology · doi:10.1002/hep.20086 · Cited by 157 · see citing works

The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases

Garbers, C., Monhasery, N., Aparicio-Siegmund, S., Lokau, J., Baran, P., Nowell, M. A., Jones, S. A., Rose-John, S., & Scheller, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.018 · Cited by 155 · see citing works

Multiple Sklerose: Neu entdeckter Signalmechanismus macht T-Zellen pathogen

(2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0042-123476 · Cited by 155 · see citing works

IL‐6 trans‐signaling is essential for the development of hepatocellular carcinoma in mice

Bergmann, J., Müller, M., Baumann, N., Reichert, M., Heneweer, C., Bolik, J., Lücke, K., Gruber, S., Carambia, A., Boretius, S., et al. (2017) · Hepatology · doi:10.1002/hep.28874 · Cited by 152 · see citing works

IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling

Hoge, J., Yan, I., Jänner, N., Schumacher, V., Chalaris, A., Steinmetz, O. M., Engel, D. R., Scheller, J., Rose‐John, S., & Mittrücker, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201044 · Cited by 151 · see citing works

Oncostatin M Receptor-β Mutations Underlie Familial Primary Localized Cutaneous Amyloidosis

Arita, K., South, A. P., Filho, G. H., Sakuma, T. H., Lai‐Cheong, J. E., Clements, S. E., Odashiro, M., Odashiro, D. N., Hans-Neto, G., Hans, N. R., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.09.002 · Cited by 149 · see citing works

More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer

Putoczki, T. L., & Ernst, M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410226 · Cited by 146 · see citing works

Randomized, controlled trial of recombinant human interleukin‐11 in patients with active Crohn's disease

Sands, B. E., Winston, B., Salzberg, B. A., Safdi, M. A., Barish, C. F., Wruble, L. D., Wilkins, R., Shapiro, M. A., Schwertschlag, U. S., & THE RHIL‐11 CROHN'S STUDY GROUP (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01179.x · Cited by 141 · see citing works

A myeloid–stromal niche and gp130 rescue in NOD2-driven Crohn’s disease

Nayar, S., Morrison, J. K., Giri, M., Gettler, K., Chuang, L.-S. F., Walker, L. A., Ko, H. M., Kenigsberg, E., Kugathasan, S., Mérad, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03484-5 · Cited by 139 · see citing works

Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation

Riethmüller, S., Somasundaram, P., Ehlers, J. C., Hung, C., Flynn, C. M., Lokau, J., Agthe, M., Düsterhöft, S., Zhu, Y., Grötzinger, J., et al. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2000080 · Cited by 137 · see citing works

Proteolytic Cleavage Governs Interleukin-11 Trans-signaling

Lokau, J., Nitz, R., Agthe, M., Monhasery, N., Aparicio-Siegmund, S., Schumacher, N., Wolf, J., Möller‐Hackbarth, K., Waetzig, G. H., Grötzinger, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.053 · Cited by 136 · see citing works

Interleukin-6 and interleukin-11: same same but different

Garbers, C., & Scheller, J. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0166 · Cited by 134 · see citing works

Regulation of Inflammatory Responses by Oncostatin M

Wallace, P. M., MacMaster, J. F., Rouleau, K. A., Brown, T. J., Loy, J. K., Donaldson, K. L., & Wahl, A. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5547 · Cited by 129 · see citing works

Coexpression of IL‐6 and soluble IL‐6R causes nodular regenerative hyperplasia and adenomas of the liver

Maione, D., Carlo, E. D., Li, W., Musiani, P., Modesti, A., Peters, M., Rose‐John, S., Rocca, C. D., Tripodi, M., Lazzaro, D., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5588 · Cited by 128 · see citing works

IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology.

Keith, J. J., Albert, L. M., Sonis, S. T., Cj, P., & Schaub, R. (1994) · PubMed · Cited by 127 · see citing works

Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice

Yamaguchi, K., Itoh, Y., Yokomizo, C., Nishimura, T., Niimi, T., Fujii, H., Okanoue, T., & Yoshikawa, T. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.75 · Cited by 125 · see citing works

Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor.

Ferrara, N., Winer, J., & Henzel, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.698 · Cited by 124 · see citing works

STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice

Mitsuyama, K., Matsumoto, S., Rose‐John, S., Suzuki, A., Hara, T., Tomiyasu, N., Handa, K., Tsuruta, O., Funabashi, H., Scheller, J., et al. (2006) · Gut · doi:10.1136/gut.2005.079343 · Cited by 120 · see citing works

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

Sands, B. E., Sandborn, W. J., Feagan, B. G., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy085 · Cited by 118 · see citing works

Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression

Cb, J., Judd, L. M., Menheniott, T. R., Kronborg, I., Dow, C., Yeomans, N. D., Boussioutas, A., Robb, L. G., & Giraud, A. (2007) · The Journal of Pathology · doi:10.1002/path.2218 · Cited by 117 · see citing works

Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats

Qiu, B., Pfeiffer, C. J., & Keith, J. C. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02087911 · Cited by 115 · see citing works

Interleukin-11 Links Oxidative Stress and Compensatory Proliferation

Nishina, T., Komazawa‐Sakon, S., Yanaka, S., Piao, X., Zheng, D.-M., Piao, J., Kojima, Y., Yamashina, S., Sano, E., Putoczki, T. L., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002056 · Cited by 115 · see citing works

IL‐6 Trans‐signaling Controls Liver Regeneration After Partial Hepatectomy

Fazel Modares, N., Polz, R., Haghighi, F., Lamertz, L., Behnke, K., Zhuang, Y., Kordes, C., Häussinger, D., Sorg, U. R., Pfeffer, K., et al. (2019) · Hepatology · doi:10.1002/hep.30774 · Cited by 113 · see citing works

Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease

Hosokawa, T., Kusugami, K., Ina, K., Ando, T., Shinoda, M., Imada, A., Ohsuga, M., Sakai, T., Matsuura, T., Ito, K., et al. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01989.x · Cited by 112 · see citing works

Inhibition of IL‐6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer

Goumas, F. A., Holmer, R., Egberts, J., Gontarewicz, A., Heneweer, C., Geisen, U., Hauser, C., Mende, M., Legler, K., Röcken, C., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29445 · Cited by 111 · see citing works

AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors

Plimack, E. R., LoRusso, P. M., Mccoon, P. E., Tang, W., Krebs, A. D., Curt, G. A., & Eckhardt, S. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0198 · Cited by 110 · see citing works

Effects of acute exercise and training on insulin action and sensitivity: focus on molecular mechanisms in muscle.

Wojtaszewski, J. F. P., & Richter, E. A. (2006) · Essays in Biochemistry · doi:10.1042/bse0420031 · Cited by 109 · see citing works

Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice

Haga, S., Ogawa, W., Inoue, H., Terui, K., Ogino, T., Igarashi, R., Takeda, K., Akira, S., Enosawa, S., Furukawa, H., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.027 · Cited by 108 · see citing works

Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease

Dambacher, J., Beigel, F., Seiderer, J., et al. (2007) · Gut · doi:10.1136/gut.2006.118679 · Cited by 106 · see citing works

Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice

Sleeman, M. W., Garcia, K., Liu, R., Murray, J. D., Malinova, L., Moncrieffe, M., Yancopoulos, G. D., & Wiegand, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2335926100 · Cited by 98 · see citing works

Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor β Subunit

Tanaka, M., Hara, T., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., & Miyajima, A. (1999) · Blood · doi:10.1182/blood.v93.3.804 · Cited by 96 · see citing works

GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study

Ellingsgaard, H., Seelig, E., Timper, K., Coslovsky, M., Soederlund, L., Lyngbæk, M. P. P., Albrechtsen, N. J. W., Schmidt‐Trucksäss, A., Hanssen, H., Frey, W. O., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05045-y · Cited by 96 · see citing works

Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy

Wu, X., Cao, Y., Xiao, H., Li, C., & Lin, J. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0921 · Cited by 92 · see citing works

The Interleukin-6 Family Cytokine Interleukin-11 Regulates Homeostatic Epithelial Cell Turnover and Promotes Gastric Tumor Development

Howlett, M., Giraud, A. S., Lescesen, H., Jackson, C. B., Kalantzis, A., van Driel, I. R., Robb, L. G., der Hoek, M. B. V., Ernst, M., Minamoto, T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.12.003 · Cited by 91 · see citing works

Ciliary neurotrophic factor is catabolic and shares with IL-6 the capacity to induce an acute phase response

Espat, N. J., Auffenberg, T., Rosenberg, J. J., et al. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.1.r185 · Cited by 89 · see citing works

Treatment of type 2 diabetes with the designer cytokine IC7Fc

Findeisen, M., Allen, T. L., Henstridge, D. C., Kammoun, H., Brandon, A. E., Baggio, L. L., Watt, K. I., Pal, M., Cron, L., Estevez, E., et al. (2019) · Nature · doi:10.1038/s41586-019-1601-9 · Cited by 86 · see citing works

Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function

Shahin, T., Aschenbrenner, D., Çağdaş, D., Bal, S., Conde, C. D., Garncarz, W., Medgyesi, D., Schwerd, T., Karaatmaca, B., Cetinkaya, P. G., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.194233 · Cited by 84 · see citing works

Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration

Drucker, C., Gewiese, J., Malchow, S., Scheller, J., & Rose-John, S. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.08.003 · Cited by 83 · see citing works

Randomized, Double Blind Controlled Trial of Subcutaneous Recombinant Human Interleukin-11 Versus Prednisolone in Active Crohn's Disease

Herrlinger, K. R., Witthoeft, T., Raedler, A., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00356.x · Cited by 81 · see citing works

Ciliary neurotrophic factor induces acute‐phase protein expression in hepatocytes

Schooltink, H., Stoyan, T., Roeb, E., Heinrich, P. C., & Rose‐John, S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81489-9 · Cited by 81 · see citing works

Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses

Lamertz, L., Rummel, F., Polz, R., Baran, P., Hansen, S., Waetzig, G. H., Moll, J. M., Floss, D. M., & Scheller, J. (2018) · Science Signaling · doi:10.1126/scisignal.aar7388 · Cited by 81 · see citing works

Mutations in the interleukin receptor IL 11 RA cause autosomal recessive Crouzon‐like craniosynostosis

Keupp, K., Li, Y., Vargel, İ., Hoischen, A., Richardson, R. J., Neveling, K., Alanay, Y., Uz, E., Elcioglu, N. H., Rachwalski, M., et al. (2013) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.28 · Cited by 78 · see citing works

Phase 1 and pharmacological trial of OPB‐31121, a signal transducer and activator of transcription‐3 inhibitor, in patients with advanced hepatocellular carcinoma

Okusaka, T., Ueno, H., Ikeda, M., Mitsunaga, S., Ozaka, M., Ishii, H., Yokosuka, O., Ooka, Y., Yoshimoto, R., Yanagihara, Y., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12504 · Cited by 77 · see citing works

Transgenic interleukin 11 expression causes cross-tissue fibro-inflammation and an inflammatory bowel phenotype in mice

Lim, W., Ng, B., Widjaja, A. A., Xie, C., Su, L., Ko, N. S. J., Lim, S.-Y., Kwek, X.-Y., Lim, S., Cook, S. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227505 · Cited by 77 · see citing works

The Regulation and Activation of Ciliary Neurotrophic Factor Signaling Proteins in Adipocytes

Zvonic, S., Cornelius, P. K., Stewart, W. C., Mynatt, R. L., & Stephens, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205871200 · Cited by 76 · see citing works

Interleukin‐27 polymorphisms are associated with inflammatory bowel diseases in a Korean population

Li, C., Zhang, Q., Lee, K., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05901.x · Cited by 76 · see citing works

Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells

Sasaoka, T., Ito, M., Yamashita, J., Nakajima, K., Tanaka, I., Narita, M., Hara, Y., Hada, K., Takahashi, M., Ohno, Y., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00329.2010 · Cited by 76 · see citing works

Untitled work

(1996) · PubMed · Cited by 75 · see citing works

Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.

Mitsuyama, K., Matsumoto, S., Masuda, J., Yamasakii, H., Kuwaki, K., Takedatsu, H., & Sata, M. (2007) · PubMed · Cited by 75 · see citing works

Profile of soluble cytokine receptors in Crohn’s disease

Gustot, T., Lemmers, A., Louis, E., Nicaise, C., Quertinmont, E., Belaiche, J., Roland, S., Gossum, A. V., Devière, J., & Franchimont, D. (2005) · Gut · doi:10.1136/gut.2004.043554 · Cited by 73 · see citing works

Interleukin-11 Reduces TLR4-Induced Colitis in TLR2-Deficient Mice and Restores Intestinal STAT3 Signaling

Gibson, D. L., Montero, M., Ropeleski, M. J., Bergstrom, K., Ma, C., Ghosh, S., Merkens, H., Huang, J. T., Månsson, L., Sham, H. P., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.057 · Cited by 72 · see citing works

Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells

Yoshizaki, A., Nakayama, T., Yamazumi, K., et al. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.4.869 · Cited by 72 · see citing works

Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning

Íñiguez, M., Berasain, C., Martínez‐Ansó, E., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061421 · Cited by 70 · see citing works

Oncostatin M Mediates STAT3-Dependent Intestinal Epithelial Restitution via Increased Cell Proliferation, Decreased Apoptosis and Upregulation of SERPIN Family Members

Beigel, F., Friedrich, M., Probst, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093498 · Cited by 68 · see citing works

The interleukin 6 pathway and atherosclerosis

Scheller, J., & Rose‐John, S. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61246-x · Cited by 68 · see citing works

STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation

Zhang, Y. S., Xin, D. E., Wang, Z., Song, X., Sun, Y., Zou, Q. C., Yue, J., Zhang, C., Zhang, J. M., Liu, Z., et al. (2019) · The EMBO Journal · doi:10.15252/embj.201899595 · Cited by 68 · see citing works

Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn’s Disease and Ulcerative Colitis

Parisinos, C. A., Serghiou, S., Katsoulis, M., George, M. J., Patel, R. S., Hemingway, H., & Hingorani, A. D. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.022 · Cited by 67 · see citing works

Oncostatin M in the anti-inflammatory response

Wahl, A. F., & Wallace, P. M. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.90003.iii75 · Cited by 66 · see citing works

TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling

Zheng, H., Yang, Y., Han, J., Jiang, W.-H., Chen, C., Wang, M.-C., Gao, R., Li, S., Tian, T., Wang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep37070 · Cited by 66 · see citing works

Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis

Henkel, J., Gärtner, D., Dorn, C., Hellerbrand, C., Schanze, N., Elz, S. R., & Püschel, G. P. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.47 · Cited by 65 · see citing works

Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy

Wei, J., Ma, L., Lai, Y.-H., Zhang, R., Li, H., Li, C., & Lin, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1072-8 · Cited by 65 · see citing works

Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections

Nanki, T., Onoue, I., Nagasaka, K., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202768 · Cited by 64 · see citing works

RecombinantHelicobacter pyloriUrease Activates Primary Mucosal Macrophages

Harris, P. R., Ernst, P. B., Kawabata, S., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/314426 · Cited by 64 · see citing works

Pituitary chromophobe adenomas consisting of prolactin cells

Kovács, K., Horváth, É., Corenblum, B., et al. (1975) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00433585 · Cited by 63 · see citing works

Arousal and motor performance.

Martens, R. (1974) · PubMed · Cited by 63 · see citing works

Effect of recombinant human interleukin‐11 on rat megakaryopoiesis and thrombopoiesis in vivo: comparative study with interleukin‐6

Yonemura, Y., Kawakita, M., Masuda, T., Fujimoto, K., & Takatsuki, K. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03020.x · Cited by 63 · see citing works

Biological functions and therapeutic opportunities of soluble cytokine receptors

Lokau, J., & Garbers, C. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.04.003 · Cited by 63 · see citing works

Cardiotrophin-1: A multifaceted cytokine

Lópeź‐Yoldi, M., Moreno-Aliaga, M. J., & Bustos, M. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.009 · Cited by 62 · see citing works

Analgesic profile of centrally administered 2-methylserotonin against acute pain in rats

Giordano, J. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90462-y · Cited by 62 · see citing works

Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation

Castaño, D., Larequi, E., Belza, I., Astudillo, A. M., Martínez‐Ansó, E., Balsinde, J., Argemí, J., Aragón, T., Moreno-Aliaga, M. J., Muntané, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.012 · Cited by 62 · see citing works

Hyperactive gp130/STAT3‐driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development

Hill, D. G., Yu, L., Gao, H., Balic, J. J., West, A. C., Oshima, H., McLeod, L., Oshima, M., Gallimore, A., D’Costa, K., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31298 · Cited by 62 · see citing works

Interleukin‐6 Levels in Colorectal Cancer Tissues

Komoda, H., Tanaka, Y., HONDA, M., Matsuo, Y., Hazama, K., & Takao, T. (1998) · World Journal of Surgery · doi:10.1007/s002689900489 · Cited by 61 · see citing works

Epithelial gp130/Stat3 functions: An intestinal signaling node in health and disease

Ernst, M., Thiem, S., Nguyen, P. M., Eissmann, M. F., & Putoczki, T. L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2013.12.006 · Cited by 60 · see citing works

Circulating IL‐6 and sIL‐6R in Patients with Hepatocellular Carcinoma

Giannitrapani, L., Cervello, M., Soresi, M., et al. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04093.x · Cited by 60 · see citing works

Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome

Chen, Y., Grigelioniené, G., Newton, P. T., Gullander, J., Elfving, M., Hammarsjö, A., Batkovskyte, D., Alsaif, H. S., Kurdi, W., Abdulwahab, F., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191306 · Cited by 60 · see citing works

Fractures of the Clivus: Classification and Clinical Features

Corradino, G., Wolf, A. L., Mirvis, S. E., et al. (1990) · Neurosurgery · doi:10.1227/00006123-199010000-00015 · Cited by 58 · see citing works

Oncostatin M: a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells

Levy, M. T., Trojanowska, M. E., & Reuben, A. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80066-5 · Cited by 57 · see citing works

Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array

Okamura, Y., Nomoto, S., Kanda, M., Li, Q., Nishikawa, Y., Sugimoto, H., Kanazumi, N., Takeda, S., & Nakao, A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.013 · Cited by 57 · see citing works

IL-31-IL-31R Interactions Limit the Magnitude of Th2 Cytokine-Dependent Immunity and Inflammation following Intestinal Helminth Infection

Perrigoue, J., Zaph, C., Guild, K. J., Du, Y., & Artis, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802459 · Cited by 55 · see citing works

Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma

Yang, S., Luo, C., Gu, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6684 · Cited by 54 · see citing works

Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy

Widjaja, A. A., Chothani, S. P., & Cook, S. A. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1761203 · Cited by 54 · see citing works

Novel role of famotidine in downregulation of matrix metalloproteinase-9 during protection of ethanol-induced acute gastric ulcer

Singh, L. P., Kundu, P., Ganguly, K., et al. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.027 · Cited by 52 · see citing works

Endogenous leukemia inhibitory factor attenuates endotoxin response

Weber, M. A., Schnyder‐Candrian, S., Schnyder, B., Quesniaux, V. F. J., Poli, V., Stewart, C. L., & Ryffel, B. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700216 · Cited by 52 · see citing works

Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling: A randomized controlled trial

Wedell‐Neergaard, A., Lang Lehrskov, L., Christensen, R. H., Legaard, G. E., Dorph, E., Larsen, M. K., Launbo, N., Fagerlind, S. R., Seide, S. K., Nymand, S. B., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.11.9 · Cited by 52 · see citing works

Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration

Dierssen, U., Beraza, N., Lutz, H. H., Liedtke, C., Ernst, M., Wasmuth, H. E., & Trautwein, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705483200 · Cited by 48 · see citing works

IL-27: a double agent in the IL-6 family

Jones, G. W., Hill, D. G., Figueras, A. C., & Jones, S. A. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13116 · Cited by 48 · see citing works

Leukemia Inhibitory Factor (LIF) Overexpression Increases the Angiogenic Potential of Bone Marrow Mesenchymal Stem/Stromal Cells

Santos, G. C., Silva, D. N., Fortuna, V., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00778 · Cited by 48 · see citing works

Role of IL-6 trans-signaling in CCl4 induced liver damage

Gewiese, J., Drucker, C., Malchow, S., Scheller, J., & Rose‐John, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.023 · Cited by 47 · see citing works

Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro

Zhu, C., Zhang, R., Liu, L., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.10.011 · Cited by 47 · see citing works

Use of Hamster Tracheal Organ Cultures for Assessing the Cocarcinogenic Effects of Inorganic Particulates on the Respiratory Epithelium1

Mossman, B. T., & Craighead, J. E. (2015) · Progress in tumor research · doi:10.1159/000402082 · Cited by 47 · see citing works

Targeting IL-6 trans-signalling: past, present and future prospects

Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524 · see citing works

The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives

Günther, C., Rothhammer, V., Karow, M., Neurath, M., & Winner, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168870 · Cited by 123 · see citing works

The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases

Wang, M.-J., Zhang, H.-L., Chen, F., Guo, X.-J., Liu, Q.-G., & Hou, J. (2024) · Experimental Hematology &amp; Oncology · doi:10.1186/s40164-024-00527-1 · Cited by 84 · see citing works

Exercise-Induced Myokines in Obesity-Related Metabolic Disorders and Cardiovascular Protection: A Narrative Review

Zhang, Y., & Qiu, Y. (2026) · Sports · doi:10.3390/sports14050212 · Cited by 3 · see citing works

LIF and OM Directly Interact with a Soluble Form of gp130, the IL-6 Receptor Signal Transducing Subunit

Modrell, B., Liu, J., Miller, H., et al. (1994) · Growth Factors · doi:10.3109/08977199409001050 · Cited by 26 · see citing works

Conditional gp130 deficient mouse mutants

Fasnacht, N., & Müller, W. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.07.001 · Cited by 60 · see citing works

The interactions of the cytokine-binding homology region and immunoglobulin-like domains of gp130 with oncostatin M: implications for receptor complex formation

Staunton, D., Hudson, K., & Heath, J. K. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.11.1093 · Cited by 30 · see citing works

The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL‐6 and the IL‐6 receptor

Horsten, U., de Leur, H. S.-V., Müllberg, J., et al. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00053-c · Cited by 49 · see citing works

Hepatology and Transplant Hepatology

Ahmad, J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7085-5 · Cited by 2 · see citing works